Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Citra Buana Prasida Tbk. (CBPE) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Citra Buana Prasida Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Citra Buana Prasida Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Citra Buana Prasida Tbk. trades at Rp535 (market cap 725.59B, 295.9K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume). The key difference: Citra Buana Prasida Tbk. and UBC Medical Indonesia Tbk. are close in size by market cap, and UBC Medical Indonesia Tbk. is more actively traded (843K versus 295.9K). Which is the better fit depends on your goals.

CBPELABS
Market Cap
725.59B635.95B
Volume
295.9K843K
Lot
2.96K8.43K
Turnover
165.79M137.6M
Average Price
560.28163.22
Value
165.79M137.6M
Indicative Equilibrium Price
580165
Indicative Equilibrium Volume
526246

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CBPE
View details
LABS
View details

About Citra Buana Prasida Tbk.

PT Citra Buana Prasida Tbk Entity which was originally named PT Prasetia Sejati was established on August 24, 2000 based on the Deed of Establishment No. 18, drawn up in the presence of Ninik Sukadarwati, SH., Notary of the Bekasi Regency Level II, in Tambun. The Entity started its commercial business in 2005.

Read more on CBPE

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS